Age Related Macular Degeneration (ARMD) Withdrawn Phase 1 Trials for Ranibizumab (DB01270)

Also known as: Age Related Macular Degeneration

IndicationStatusPhase
DBCOND0055169 (Age Related Macular Degeneration (ARMD))Withdrawn1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00726466Study of Efalizumab Combined With Intravitreal Ranibizumab in the Treatment of Age-Related Macular DegenerationTreatment